EXAVIR THERAPEUTICS INC.

Exavir Therapeutics

OMAHA, United States · Founded 2023 · $5.0M raised

Headquarters
OMAHA, Nebraska
Employees
1–10
Founded
2023
Total Funding
$5.0M
Last Round
$4.0M SeedJun 2024
Rounds
2

About

R&D company with 1 SBIR/STTR awards from Department of Health and Human Services.

Summary

EXAVIR THERAPEUTICS INC. is a company based in OMAHA, United States, founded in 2023. It has raised $5.0M in total across 2 rounds, most recently a $4.0M Seed round in Jun 2024. Investors include AlleyCorp, National Institute of Allergy and Infectious Diseases and Gilead Sciences.

Tech & App Stack

2 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundJun 2024
$4.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors